MOLECULAR AND IMMUNOLOGICAL APPROACHES TO VACCINE DESIGN
November 29 - December 2, 2007
Abstract Deadline: October 5, 2007

Organizers:
Peter Beverley, Jenner Institute for Vaccine Research, UK
Kathrin Jansen, Wyeth Pharmaceuticals
Susan Swain, Trudeau Institute

Past Program

We are pleased to announce the fifth Cold Spring Harbor winter biotechnology conference on Molecular and Immunological Approaches to Vaccine Design, which will begin at 7:30 pm on Thursday, November 29 and run through lunch on Sunday, December 2, 2007. We are looking forward to a broad-based meeting, and abstracts are welcomed on all scientific topics related to the design of novel vaccines, the immune response and delivery systems.

The format of the meeting will include six oral sessions consisting of invited and short talks, limited to approximately 15 minutes, principally on unpublished work. As usual at Cold Spring Harbor Meetings, all abstracts of both poster and platform sessions will be published in an abstract book given to all the participants.

Topics:
• CD4 T-cell Subsets and Immunity
• Generating Protective Immune Memory
• Effector Mechanisms Against Infectious Agents
• Adjuvants for Improved Vaccines
• Application of New Technologies to Difficult Diseases
• Vaccines in the Young and the Old

Speakers:
Elodie Belnoue, CMU, Switzerland
Robert Coffman, Dynavax Technologies, Berkeley, California
Andrea Cooper, Trudeau Institute, Inc., New York
Heather Davis, Coley Pharmaceutical Group, Kanata, Canada
Lucy Dorrell, John Radcliffe Hospital, UK
Simon Draper, Wellcome Trust Centre for Human Genetics, UK
Beatrix Grubeck-Loebenstein, Austrian Academy of Sciences,
Innsbruck, Austria
Kim Hasenkrug, Rocky Mountain Laboratories, NIAID,NIH, Montana
Dan Littman, HHMI/Skirball Institute of Biomolecular Medicine,New York, New York
Janet McElaney, University of Connecticut, Farmington, CT
Benedita Rocha, INSERM U591, Paris, France
Stephen Schoenberger, La Jolla Institute for Allergy & Immunology, CA
Robert Seder, Vaccine Reserach Center, NIAID, NIH, Bethesda, Maryland
Alan Shaw, Vaxinnate Corporation, New Jersey
Alan Sher, National Institute of Allergy & Infectious Diseases, Bethesda, Maryland

Abstracts should contain only new and unpublished material and must be submitted electronically by the abstract deadline. Selection of material for oral and poster presentation will be made by the organizers and individual session chairs. Status (talk/poster) of abstracts will be posted on our web site as soon as decisions have been made by the organizers.

We are eager to have as many young people as possible attend and have applied for funds from government and industry to partially support graduate students and postdocs. Apply in writing to meetings@cshl.edu stating need for financial support - preference is given to those submitting abstracts.

We look forward to seeing you at Cold Spring Harbor in December.

This conference is supported in part by funds provided by:

---

Regular packages are all inclusive and cover registration, food, housing, parking, wine-and-cheese party, lobster banquet, etc. No Housing packages include all costs except housing. Full payment is due 4 weeks prior to the meeting.